Substipharm Sustainability Profile
Substipharm, a leading player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe. Founded in 2008, the company has established itself as a key provider of high-quality generic and specialty medicines, focusing on therapeutic areas such as oncology, cardiology, and neurology. With a commitment to innovation, Substipharm offers a unique portfolio of products that cater to the evolving needs of healthcare professionals and patients alike. The company’s dedication to quality and regulatory compliance has positioned it as a trusted partner in the pharmaceutical sector. Notable achievements include successful partnerships with various healthcare organisations, enhancing its market presence and reputation for excellence in drug development and distribution.
DitchCarbon Score
How does Substipharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Substipharm's score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Substipharm's reported carbon emissions
Substipharm, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Substipharm may still be in the early stages of developing its climate commitments or reporting frameworks. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. However, without specific emissions data or targets, it is challenging to assess Substipharm's position relative to industry standards. As the company progresses, it may consider establishing measurable goals aligned with global climate initiatives to enhance its environmental impact and transparency.
How Carbon Intensive is Substipharm's Industry?
How Carbon Intensive is Substipharm's Location?
Substipharm's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Substipharm has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
